<DOC>
	<DOCNO>NCT01340417</DOCNO>
	<brief_summary>The general goal present study examine developmental change cause melatonin preterm term newborn . The major brain lesion associate cerebral palsy cognitive impairment preterm infant periventricular white matter damage ( WMD ) . At present time , despite major improvement neonatal care , establish therapeutic regimen treatment brain lesion preterms . Melatonin secrete pineal gland ; melatonin 's neuroprotective action well document animal experimental model . Neuroprotection believe stem direct free radical scavenging , indirect antioxidant activity . Originality Several report describe melatonin secretion old child , observe melatonin concentration first year life . Very little known fetal pineal melatonin synthesis nothing prenatal age melatonin synthesis start . Premature infants 3 month delay development melatonin rhythmicity compare full-term infant . One study find discordant data decrease melatonin value around term . The absence longitudinal study low number child include make interpretation difficult secretion melatonin newborn . Hypothesis : Infants bear 28 week gestation melatonin deficiency ( 50pg/ml ) , compare newborn term ( 100pg/ml ) . Study design : prospective , longitudinal , multicenter trial 3 Neonatal Intensive Care Units Ile de France . Specific aim compare developmental change melatonin preterm term newborn ( 200 infant mother : 4 group 50 infant : 24-27GA +6d ; 28-32 GA +6d ; 33-36 GA +6d ; 37-41 GA +6d ) . Secondary aim follow : - determine Melatonin creatinin excretion preterm infant - correlate serum melatonin secretion urinary melatonin 6-sulfatoxymelatonin excretion - determine endogenous melatonin production human pineal - correlate genetic variation different level melatonin premature infant - assess clinical neurological outcome term Clinical impact The present clinical project part translational approach , expect data infant bear 28 week gestation melatonin deficiency participate determine potential use melatonin neuroprotectant human preterm neonate .</brief_summary>
	<brief_title>Melatonin Levels Preterm Term Newborn Infants</brief_title>
	<detailed_description>The general goal present study examine developmental change cause melatonin preterm compare term newborn . This secretion study child mother 's blood , child 's urine , mother 's milk woman breastfeed ( 200 infant mother : 4 group 50 infant : 24-27 gestational age ( GA ) +6d ; 28-32 GA +6d ; 33-36 GA +6d ; 37-41 GA +6d ) . Secondary aim follow : determine Melatonin creatinin excretion preterm infant , correlate serum melatonin secretion urinary melatonin 6-sulfatoxymelatonin excretion , determine endogenous melatonin production human pineal , correlate genetic variation different level melatonin premature infant , assess clinical neurological outcome term . Study duration patient Study duration one year ( inclusion time : 9 month ) Duration mother 's inclusion:3 day delivery 34 41+6d week gestation ( two blood sample maternal vein umbilical vein delivery one mother 's milk sample third day delivery , D3 ) 15 day 3 month delivery 24 33+6d week gestation ( two blood sample maternal vein umbilical vein delivery mother 's milk sample third day delivery , D10-D15 , D30 , D60 term age Duration infant 's inclusion : - 3 day delivery 34 41+6d week gestation ( 1 blood sample third day ( D3 ) delivery 4 urinary sample birth D3 ) - 15 day 3 month delivery 24 33+6d week gestation ( blood urinary sample third day delivery , D10-D15 , D30 , D60 term ( 37-42 week gestational age ) Population study All preterm term newborn 3 participate center , evaluated term eligibility . Their clinical characteristic compare criterion inclusion exclusion enter study . The inclusion preterm 24 GA justified assumption responsibility earlier population 2009 ( limit viability 24 GA and/or birth weight &gt; 500g ) . The group term infant ( 37-41 GA +6d ) correspond inclusion new-born baby good health maternity . Descriptive analysis The quantitative variable describe form average ( standard deviation ) median ( quartile ) accord Gaussian nature . The qualitative variable describe manpower frequency . Analyzes criterion judgment The principal analysis compare rate child deprive melatonin 4 group . This comparison carry test chi-2 Fisher suitable . Nevertheless analysis refine model plasmatic secretion accord gestational age hour melatonin measurement . This modeling use either mixed model , nonlinear model like model use pharmacokinetic . In way model urinary level melatonin mother 's milk take account parameter previously repetition measurement . Some parameter use like variable adjustment like luminous environment , preeclampsia , sex , intrauterine growth restrict infant , multiple pregnancy , way childbirth . The plan statistical analysis finalize end study data management subject Master biostatistics . The measurement cortisol , parameter ionogram , urea , creatinin , serotonin compare 4 group use parametric test ( ANOVA ) parametric ( KRUSKALL-Wallis ) accord Gaussian nature variable . The measurement ( blood , urine ) describe course time accord gestational age . The analyzes carry software SAS 9.02 . Clinical impact : The present clinical project part translational approach , expect data infant bear 28 week gestation melatonin deficiency participate , addition exist data ongoing study animal model , determine potential use melatonin neuroprotectant human preterm neonate . It 's important underline study must consider interventional study . Indeed , study patient many taking modality common practice patient n't taking : - measurement melatonin level urine , blood , milk - measurement Serum Cortisol concentration urinary excretion - measurement Serum Serotonin level</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<criteria>Mother : Consent form mother guardian Age ≥ 18 year Mother Heath insurance Newborn : Infants bear 24+0 et 41+6 week gestation Infants inform consent mother guardian mother 's social insurance Mother : Chronic pathology Treatment : Carbamazepine , betablockers , rifampicin , quinolones , cimetidine , 5Methoxypsoralen bergapten , 8 methoxypsoralen ( Methoxsalen ) , CIRCADIN® Newborn : Congenital malformation Dermatosis Treatment : cimetidine</criteria>
	<gender>All</gender>
	<minimum_age>24 Weeks</minimum_age>
	<maximum_age>41 Weeks</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>melatonin</keyword>
	<keyword>preterm</keyword>
	<keyword>deficiency</keyword>
	<keyword>neuroprotection</keyword>
</DOC>